APRIL HUNT: Open Payments
NPI 1467716548 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 19 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $39 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Exact Sciences Corporation | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, Kerendia, AREXVY, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, IBSRELA.
Industry payments across MS — which companies pay providers there.
